April 23-24: IPOG 3rd Annual Minimally Invasive Lung Cancer and Pleural Disease Diagnostics and Treatment Conference | Baltimore
3rd Annual Minimally Invasive Lung Cancer and Pleural Disease Diagnostics and Treatment Conference – Interventional Pulmonary Outcomes Group
Event: Interventional Pulmonary Outcomes Group 3rd Annual Minimally Invasive Lung Cancer and Pleural Disease Diagnostics and Treatment Conference
Dates: April 2, 2025
Location: Johns Hopkins University School of Medicine, Baltimore
NanOlogy representatives will be at this conference. Email nanology@DFB.com if you would like to schedule a meeting. NanOlogy is a clinical-stage oncology company with a proprietary particle engineering technology that forms patented large surface area microparticles (LSAMS) of pure drug for solid tumor-directed delivery to maximize drug in the tumor and minimize systemic toxicity. Clinical trials in multiple solid tumors (pancreas, lung, bladder, prostate, ovarian, peritoneal) across more than 170 patients to date have demonstrated promising tumor response and immunomodulation with minimal toxicity.
For more info visit our website: nanology.us